It has been almost seven years since the Government of India, under the aegis of the Department of Pharmaceuticals (DoP), had established a committee tasked with framing a mechanism that would serve to bring down the price of patented medicines within the country by way of negotiation and/or reference pricing. Considering the exorbitant pricing that some of the patented drugs are subjected to, this move was certainly a laudable one, aimed to provide much-needed affordability to especially the life-saving...
↧